<?xml version="1.0" encoding="UTF-8" ?>
<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>β-cells cis-regulatory networks and type 1 diabetes</dc:title>
<dc:creator>Ramos Rodríguez, Mireia</dc:creator>
<dc:contributor>Pasquali, Lorenzo</dc:contributor>
<dc:contributor>Orozco López, Modesto</dc:contributor>
<dc:contributor>Universitat de Barcelona. Facultat de Biologia</dc:contributor>
<dc:subject>Regulació genètica</dc:subject>
<dc:subject>Regulación genética</dc:subject>
<dc:subject>Genetic regulation</dc:subject>
<dc:subject>Cromatina</dc:subject>
<dc:subject>Chromatin</dc:subject>
<dc:subject>Genètica humana</dc:subject>
<dc:subject>Genética humana</dc:subject>
<dc:subject>Human genetics</dc:subject>
<dc:subject>Diabetis</dc:subject>
<dc:subject>Diabetes</dc:subject>
<dc:subject>Bioinformàtica</dc:subject>
<dc:subject>Bioinformática</dc:subject>
<dc:subject>Bioinformatics</dc:subject>
<dc:subject>Ciències Experimentals i Matemàtiques</dc:subject>
<dc:subject>575</dc:subject>
<dc:subject>61</dc:subject>
<dc:description>Programa de Doctorat en Biomedicina / Tesi realitzada a l'Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)</dc:description>
<dc:description>Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</dc:description>
<dc:date>2021-07-21T07:42:30Z</dc:date>
<dc:date>2021-07-21T07:42:30Z</dc:date>
<dc:date>2020-11-06</dc:date>
<dc:type>info:eu-repo/semantics/doctoralThesis</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:identifier>http://hdl.handle.net/10803/672192</dc:identifier>
<dc:language>eng</dc:language>
<dc:rights>L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by-nc/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>221 p.</dc:format>
<dc:format>application/pdf</dc:format>
<dc:format>application/pdf</dc:format>
<dc:publisher>Universitat de Barcelona</dc:publisher>
<dc:source>TDX (Tesis Doctorals en Xarxa)</dc:source>
</oai_dc:dc>
<?xml version="1.0" encoding="UTF-8" ?>
<dim:dim schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
<dim:field element="contributor" mdschema="dc">Universitat de Barcelona. Facultat de Biologia</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Ramos Rodríguez, Mireia</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="authoremail">mireiarr9@gmail.com</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="authoremailshow">false</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="director">Pasquali, Lorenzo</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="tutor">Orozco López, Modesto</dim:field>
<dim:field element="date" mdschema="dc" qualifier="accessioned">2021-07-21T07:42:30Z</dim:field>
<dim:field element="date" mdschema="dc" qualifier="available">2021-07-21T07:42:30Z</dim:field>
<dim:field element="date" mdschema="dc" qualifier="issued">2020-11-06</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="uri">http://hdl.handle.net/10803/672192</dim:field>
<dim:field element="description" mdschema="dc">Programa de Doctorat en Biomedicina / Tesi realitzada a l'Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)</dim:field>
<dim:field element="description" mdschema="dc" qualifier="abstract">Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</dim:field>
<dim:field element="format" mdschema="dc" qualifier="extent">221 p.</dim:field>
<dim:field element="format" mdschema="dc" qualifier="mimetype">application/pdf</dim:field>
<dim:field element="language" mdschema="dc" qualifier="iso">eng</dim:field>
<dim:field element="publisher" mdschema="dc">Universitat de Barcelona</dim:field>
<dim:field element="rights" mdschema="dc" qualifier="license">L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by-nc/4.0/</dim:field>
<dim:field element="rights" mdschema="dc" qualifier="accessLevel">info:eu-repo/semantics/openAccess</dim:field>
<dim:field element="source" mdschema="dc">TDX (Tesis Doctorals en Xarxa)</dim:field>
<dim:field element="subject" mdschema="dc">Regulació genètica</dim:field>
<dim:field element="subject" mdschema="dc">Regulación genética</dim:field>
<dim:field element="subject" mdschema="dc">Genetic regulation</dim:field>
<dim:field element="subject" mdschema="dc">Cromatina</dim:field>
<dim:field element="subject" mdschema="dc">Chromatin</dim:field>
<dim:field element="subject" mdschema="dc">Genètica humana</dim:field>
<dim:field element="subject" mdschema="dc">Genética humana</dim:field>
<dim:field element="subject" mdschema="dc">Human genetics</dim:field>
<dim:field element="subject" mdschema="dc">Diabetis</dim:field>
<dim:field element="subject" mdschema="dc">Diabetes</dim:field>
<dim:field element="subject" mdschema="dc">Bioinformàtica</dim:field>
<dim:field element="subject" mdschema="dc">Bioinformática</dim:field>
<dim:field element="subject" mdschema="dc">Bioinformatics</dim:field>
<dim:field element="subject" mdschema="dc" qualifier="other">Ciències Experimentals i Matemàtiques</dim:field>
<dim:field element="subject" mdschema="dc" qualifier="udc">575</dim:field>
<dim:field element="subject" mdschema="dc" qualifier="udc">61</dim:field>
<dim:field element="title" mdschema="dc">β-cells cis-regulatory networks and type 1 diabetes</dim:field>
<dim:field element="type" mdschema="dc">info:eu-repo/semantics/doctoralThesis</dim:field>
<dim:field element="type" mdschema="dc">info:eu-repo/semantics/publishedVersion</dim:field>
<dim:field element="embargo" mdschema="dc" qualifier="terms">cap</dim:field>
</dim:dim>
<?xml version="1.0" encoding="UTF-8" ?>
<thesis schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
<title>β-cells cis-regulatory networks and type 1 diabetes</title>
<creator>Ramos Rodríguez, Mireia</creator>
<contributor>mireiarr9@gmail.com</contributor>
<contributor>false</contributor>
<contributor>Pasquali, Lorenzo</contributor>
<contributor>Orozco López, Modesto</contributor>
<subject>Regulació genètica</subject>
<subject>Regulación genética</subject>
<subject>Genetic regulation</subject>
<subject>Cromatina</subject>
<subject>Chromatin</subject>
<subject>Genètica humana</subject>
<subject>Genética humana</subject>
<subject>Human genetics</subject>
<subject>Diabetis</subject>
<subject>Diabetes</subject>
<subject>Bioinformàtica</subject>
<subject>Bioinformática</subject>
<subject>Bioinformatics</subject>
<description>Programa de Doctorat en Biomedicina / Tesi realitzada a l'Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)</description>
<description>Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</description>
<date>2021-07-21</date>
<date>2021-07-21</date>
<date>2020-11-06</date>
<type>info:eu-repo/semantics/doctoralThesis</type>
<type>info:eu-repo/semantics/publishedVersion</type>
<identifier>http://hdl.handle.net/10803/672192</identifier>
<language>eng</language>
<rights>L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by-nc/4.0/</rights>
<rights>info:eu-repo/semantics/openAccess</rights>
<publisher>Universitat de Barcelona</publisher>
<source>TDX (Tesis Doctorals en Xarxa)</source>
</thesis>
<?xml version="1.0" encoding="UTF-8" ?>
<record schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield ind1=" " ind2=" " tag="042">
<subfield code="a">dc</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Ramos Rodríguez, Mireia</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="260">
<subfield code="c">2020-11-06</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="520">
<subfield code="a">Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">http://hdl.handle.net/10803/672192</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Regulació genètica</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Regulación genética</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Genetic regulation</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Cromatina</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Chromatin</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Genètica humana</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Genética humana</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Human genetics</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Diabetis</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Diabetes</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Bioinformàtica</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Bioinformática</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Bioinformatics</subfield>
</datafield>
<datafield ind1="0" ind2="0" tag="245">
<subfield code="a">β-cells cis-regulatory networks and type 1 diabetes</subfield>
</datafield>
</record>
<?xml version="1.0" encoding="UTF-8" ?>
<record schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>nam a 5i 4500</leader>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Regulació genètica</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Regulación genética</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Genetic regulation</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Cromatina</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Chromatin</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Genètica humana</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Genética humana</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Human genetics</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Diabetis</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Diabetes</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Bioinformàtica</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Bioinformática</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Bioinformatics</subfield>
</datafield>
<datafield ind1="1" ind2="0" tag="245">
<subfield code="a">β-cells cis-regulatory networks and type 1 diabetes</subfield>
</datafield>
<datafield ind1=" " ind2="1" tag="264">
<subfield code="a">[Barcelona] :</subfield>
<subfield code="b">Universitat de Barcelona,</subfield>
<subfield code="c">2021</subfield>
</datafield>
<datafield ind1="4" ind2="0" tag="856">
<subfield code="z">Accés lliure</subfield>
<subfield code="u">http://hdl.handle.net/10803/672192</subfield>
</datafield>
<controlfield tag="007">cr |||||||||||</controlfield>
<controlfield tag="008">AAMMDDs2021 sp ||||fsm||||0|| 0 eng|c</controlfield>
<datafield ind1="1" ind2=" " tag="100">
<subfield code="a">Ramos Rodríguez, Mireia,</subfield>
<subfield code="e">autor</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="300">
<subfield code="a">1 recurs en línia (221 pàgines)</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="500">
<subfield code="a">Programa de Doctorat en Biomedicina / Tesi realitzada a l'Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="502">
<subfield code="g">Tesi</subfield>
<subfield code="b">Doctorat</subfield>
<subfield code="c">Universitat de Barcelona. Facultat de Biologia</subfield>
<subfield code="d">2020</subfield>
</datafield>
<datafield ind1="2" ind2=" " tag="710">
<subfield code="a">Universitat de Barcelona. Facultat de Biologia</subfield>
</datafield>
<datafield ind1=" " ind2="4" tag="655">
<subfield code="a">Tesis i dissertacions electròniques</subfield>
</datafield>
<datafield ind1="1" ind2=" " tag="700">
<subfield code="a">Pasquali, Lorenzo,</subfield>
<subfield code="e">supervisor acadèmic</subfield>
</datafield>
<datafield ind1="1" ind2=" " tag="700">
<subfield code="a">Orozco López, Modesto,</subfield>
<subfield code="e">supervisor acadèmic</subfield>
</datafield>
<datafield ind1="0" ind2=" " tag="730">
<subfield code="a">TDX</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="520">
<subfield code="a">Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="998">
<subfield code="a">b</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="040">
<subfield code="a">ES-BaCBU</subfield>
<subfield code="b">cat</subfield>
<subfield code="e">rda</subfield>
<subfield code="c">ES-BaCBU</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="336">
<subfield code="a">text</subfield>
<subfield code="b">txt</subfield>
<subfield code="2">rdacontent</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="337">
<subfield code="a">informàtic</subfield>
<subfield code="b">c</subfield>
<subfield code="2">rdamedia</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="338">
<subfield code="a">recurs en línia</subfield>
<subfield code="b">cr</subfield>
<subfield code="2">rdacarrier</subfield>
</datafield>
</record>
<?xml version="1.0" encoding="UTF-8" ?>
<mets ID=" DSpace_ITEM_10803-672192" OBJID=" hdl:10803/672192" PROFILE="DSpace METS SIP Profile 1.0" TYPE="DSpace ITEM" schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd">
<metsHdr CREATEDATE="2024-04-30T15:07:10Z">
<agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
<name>TDX (Tesis Doctorals en Xarxa)</name>
</agent>
</metsHdr>
<dmdSec ID="DMD_10803_672192">
<mdWrap MDTYPE="MODS">
<xmlData schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Ramos Rodríguez, Mireia</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">authoremail</mods:roleTerm>
</mods:role>
<mods:namePart>mireiarr9@gmail.com</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">authoremailshow</mods:roleTerm>
</mods:role>
<mods:namePart>false</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">director</mods:roleTerm>
</mods:role>
<mods:namePart>Pasquali, Lorenzo</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">tutor</mods:roleTerm>
</mods:role>
<mods:namePart>Orozco López, Modesto</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2021-07-21T07:42:30Z</mods:dateAccessioned>
</mods:extension>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2021-07-21T07:42:30Z</mods:dateAvailable>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2020-11-06</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="uri">http://hdl.handle.net/10803/672192</mods:identifier>
<mods:abstract>Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</mods:abstract>
<mods:language>
<mods:languageTerm authority="rfc3066">eng</mods:languageTerm>
</mods:language>
<mods:subject>
<mods:topic>Regulació genètica</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Regulación genética</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Genetic regulation</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Cromatina</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Chromatin</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Genètica humana</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Genética humana</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Human genetics</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Diabetis</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Diabetes</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Bioinformàtica</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Bioinformática</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Bioinformatics</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>β-cells cis-regulatory networks and type 1 diabetes</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/doctoralThesis info:eu-repo/semantics/publishedVersion</mods:genre>
</mods:mods>
</xmlData>
</mdWrap>
</dmdSec>
<amdSec ID="FO_10803_672192_1">
<techMD ID="TECH_O_10803_672192_1">
<mdWrap MDTYPE="PREMIS">
<xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
<premis:premis>
<premis:object>
<premis:objectIdentifier>
<premis:objectIdentifierType>URL</premis:objectIdentifierType>
<premis:objectIdentifierValue>https://www.tdx.cat/bitstream/10803/672192/1/MRR_PhD_THESIS.pdf</premis:objectIdentifierValue>
</premis:objectIdentifier>
<premis:objectCategory>File</premis:objectCategory>
<premis:objectCharacteristics>
<premis:fixity>
<premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
<premis:messageDigest>b17f8a007b83258c0d8ed84dcc314803</premis:messageDigest>
</premis:fixity>
<premis:size>32775164</premis:size>
<premis:format>
<premis:formatDesignation>
<premis:formatName>application/pdf</premis:formatName>
</premis:formatDesignation>
</premis:format>
</premis:objectCharacteristics>
<premis:originalName>MRR_PhD_THESIS.pdf</premis:originalName>
</premis:object>
</premis:premis>
</xmlData>
</mdWrap>
</techMD>
</amdSec>
<fileSec>
<fileGrp USE="ORIGINAL">
<file ADMID="FO_10803_672192_1" CHECKSUM="b17f8a007b83258c0d8ed84dcc314803" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_10803_672192_1" ID="BITSTREAM_ORIGINAL_10803_672192_1" MIMETYPE="application/pdf" SEQ="1" SIZE="32775164">
</file>
</fileGrp>
</fileSec>
<structMap LABEL="DSpace Object" TYPE="LOGICAL">
<div ADMID="DMD_10803_672192" TYPE="DSpace Object Contents">
<div TYPE="DSpace BITSTREAM">
</div>
</div>
</structMap>
</mets>
<?xml version="1.0" encoding="UTF-8" ?>
<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Ramos Rodríguez, Mireia</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2021-07-21T07:42:30Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2021-07-21T07:42:30Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2020-11-06</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="uri">http://hdl.handle.net/10803/672192</mods:identifier>
<mods:abstract>Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by-nc/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:subject>
<mods:topic>Regulació genètica</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Regulación genética</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Genetic regulation</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Cromatina</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Chromatin</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Genètica humana</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Genética humana</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Human genetics</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Diabetis</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Diabetes</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Bioinformàtica</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Bioinformática</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Bioinformatics</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>β-cells cis-regulatory networks and type 1 diabetes</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/doctoralThesis</mods:genre>
<mods:genre>info:eu-repo/semantics/publishedVersion</mods:genre>
</mods:mods>
<?xml version="1.0" encoding="UTF-8" ?>
<oaire:record schemaLocation="http://namespaceopenaire.eu/schema/oaire/">
<dc:title>β-cells cis-regulatory networks and type 1 diabetes</dc:title>
<datacite:creator>
<datacite:creatorName>Ramos Rodríguez, Mireia</datacite:creatorName>
</datacite:creator>
<datacite:contributor>mireiarr9@gmail.com</datacite:contributor>
<datacite:contributor>false</datacite:contributor>
<datacite:contributor>Pasquali, Lorenzo</datacite:contributor>
<datacite:contributor>Orozco López, Modesto</datacite:contributor>
<datacite:contributor>Universitat de Barcelona. Facultat de Biologia</datacite:contributor>
<dc:subject>Regulació genètica</dc:subject>
<dc:subject>Regulación genética</dc:subject>
<dc:subject>Genetic regulation</dc:subject>
<dc:subject>Cromatina</dc:subject>
<dc:subject>Chromatin</dc:subject>
<dc:subject>Genètica humana</dc:subject>
<dc:subject>Genética humana</dc:subject>
<dc:subject>Human genetics</dc:subject>
<dc:subject>Diabetis</dc:subject>
<dc:subject>Diabetes</dc:subject>
<dc:subject>Bioinformàtica</dc:subject>
<dc:subject>Bioinformática</dc:subject>
<dc:subject>Bioinformatics</dc:subject>
<dc:subject>Ciències Experimentals i Matemàtiques</dc:subject>
<dc:subject>575</dc:subject>
<dc:subject>61</dc:subject>
<dc:description>Programa de Doctorat en Biomedicina / Tesi realitzada a l'Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)</dc:description>
<dc:description>Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</dc:description>
<dc:date>2021-07-21T07:42:30Z</dc:date>
<dc:date>2021-07-21T07:42:30Z</dc:date>
<dc:date>2020-11-06</dc:date>
<dc:type>info:eu-repo/semantics/doctoralThesis</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<datacite:alternateIdentifier>http://hdl.handle.net/10803/672192</datacite:alternateIdentifier>
<dc:language>eng</dc:language>
<dc:rights>L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by-nc/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>221 p.</dc:format>
<dc:format>application/pdf</dc:format>
<dc:format>application/pdf</dc:format>
<dc:publisher>Universitat de Barcelona</dc:publisher>
<dc:source>TDX (Tesis Doctorals en Xarxa)</dc:source>
<oaire:file>https://www.tdx.cat/bitstream/10803/672192/1/MRR_PhD_THESIS.pdf</oaire:file>
</oaire:record>
<?xml version="1.0" encoding="UTF-8" ?>
<atom:entry schemaLocation="http://www.w3.org/2005/Atom http://www.kbcafe.com/rss/atom.xsd.xml">
<atom:id>http://hdl.handle.net/10803/672192/ore.xml</atom:id>
<atom:published>2021-07-21T07:42:30Z</atom:published>
<atom:updated>2021-07-21T07:42:30Z</atom:updated>
<atom:source>
<atom:generator>TDX (Tesis Doctorals en Xarxa)</atom:generator>
</atom:source>
<atom:title>β-cells cis-regulatory networks and type 1 diabetes</atom:title>
<atom:author>
<atom:name>Ramos Rodríguez, Mireia</atom:name>
</atom:author>
<oreatom:triples>
<rdf:Description about="http://hdl.handle.net/10803/672192/ore.xml#atom">
<dcterms:modified>2021-07-21T07:42:30Z</dcterms:modified>
</rdf:Description>
<rdf:Description about="https://www.tdx.cat/bitstream/10803/672192/1/MRR_PhD_THESIS.pdf">
<dcterms:description>ORIGINAL</dcterms:description>
</rdf:Description>
<rdf:Description about="https://www.tdx.cat/bitstream/10803/672192/2/license_url">
<dcterms:description>CC-LICENSE</dcterms:description>
</rdf:Description>
<rdf:Description about="https://www.tdx.cat/bitstream/10803/672192/3/license_text">
<dcterms:description>CC-LICENSE</dcterms:description>
</rdf:Description>
<rdf:Description about="https://www.tdx.cat/bitstream/10803/672192/4/license_rdf">
<dcterms:description>CC-LICENSE</dcterms:description>
</rdf:Description>
<rdf:Description about="https://www.tdx.cat/bitstream/10803/672192/5/MRR_PhD_THESIS.pdf.xml">
<dcterms:description>MEDIA_DOCUMENT</dcterms:description>
</rdf:Description>
</oreatom:triples>
</atom:entry>
<?xml version="1.0" encoding="UTF-8" ?>
<qdc:qualifieddc schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
<dc:title>β-cells cis-regulatory networks and type 1 diabetes</dc:title>
<dc:creator>Ramos Rodríguez, Mireia</dc:creator>
<dc:contributor>Pasquali, Lorenzo</dc:contributor>
<dc:contributor>Orozco López, Modesto</dc:contributor>
<dc:subject>Regulació genètica</dc:subject>
<dc:subject>Regulación genética</dc:subject>
<dc:subject>Genetic regulation</dc:subject>
<dc:subject>Cromatina</dc:subject>
<dc:subject>Chromatin</dc:subject>
<dc:subject>Genètica humana</dc:subject>
<dc:subject>Genética humana</dc:subject>
<dc:subject>Human genetics</dc:subject>
<dc:subject>Diabetis</dc:subject>
<dc:subject>Diabetes</dc:subject>
<dc:subject>Bioinformàtica</dc:subject>
<dc:subject>Bioinformática</dc:subject>
<dc:subject>Bioinformatics</dc:subject>
<dcterms:abstract>Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</dcterms:abstract>
<dcterms:dateAccepted>2021-07-21T07:42:30Z</dcterms:dateAccepted>
<dcterms:available>2021-07-21T07:42:30Z</dcterms:available>
<dcterms:created>2021-07-21T07:42:30Z</dcterms:created>
<dcterms:issued>2020-11-06</dcterms:issued>
<dc:type>info:eu-repo/semantics/doctoralThesis</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:identifier>http://hdl.handle.net/10803/672192</dc:identifier>
<dc:language>eng</dc:language>
<dc:rights>L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by-nc/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:publisher>Universitat de Barcelona</dc:publisher>
<dc:source>TDX (Tesis Doctorals en Xarxa)</dc:source>
</qdc:qualifieddc>
<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
<ow:Publication about="oai:www.tdx.cat:10803/672192">
<dc:title>β-cells cis-regulatory networks and type 1 diabetes</dc:title>
<dc:creator>Ramos Rodríguez, Mireia</dc:creator>
<dc:contributor>mireiarr9@gmail.com</dc:contributor>
<dc:contributor>false</dc:contributor>
<dc:contributor>Pasquali, Lorenzo</dc:contributor>
<dc:contributor>Orozco López, Modesto</dc:contributor>
<dc:subject>Regulació genètica</dc:subject>
<dc:subject>Regulación genética</dc:subject>
<dc:subject>Genetic regulation</dc:subject>
<dc:subject>Cromatina</dc:subject>
<dc:subject>Chromatin</dc:subject>
<dc:subject>Genètica humana</dc:subject>
<dc:subject>Genética humana</dc:subject>
<dc:subject>Human genetics</dc:subject>
<dc:subject>Diabetis</dc:subject>
<dc:subject>Diabetes</dc:subject>
<dc:subject>Bioinformàtica</dc:subject>
<dc:subject>Bioinformática</dc:subject>
<dc:subject>Bioinformatics</dc:subject>
<dc:description>Programa de Doctorat en Biomedicina / Tesi realitzada a l'Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)</dc:description>
<dc:description>Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</dc:description>
<dc:date>2021-07-21T07:42:30Z</dc:date>
<dc:date>2021-07-21T07:42:30Z</dc:date>
<dc:date>2020-11-06</dc:date>
<dc:type>info:eu-repo/semantics/doctoralThesis</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:identifier>http://hdl.handle.net/10803/672192</dc:identifier>
<dc:language>eng</dc:language>
<dc:rights>L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by-nc/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:publisher>Universitat de Barcelona</dc:publisher>
<dc:source>TDX (Tesis Doctorals en Xarxa)</dc:source>
</ow:Publication>
</rdf:RDF>
<?xml version="1.0" encoding="UTF-8" ?>
<uketd_dc:uketddc schemaLocation="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/ http://naca.central.cranfield.ac.uk/ethos-oai/2.0/uketd_dc.xsd">
<dc:title>β-cells cis-regulatory networks and type 1 diabetes</dc:title>
<dc:creator>Ramos Rodríguez, Mireia</dc:creator>
<dcterms:abstract>Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</dcterms:abstract>
<uketdterms:institution>Universitat de Barcelona</uketdterms:institution>
<dcterms:issued>2020-11-06</dcterms:issued>
<dc:type>info:eu-repo/semantics/doctoralThesis</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:language type="dcterms:ISO639-2">eng</dc:language>
<dcterms:isReferencedBy>http://hdl.handle.net/10803/672192</dcterms:isReferencedBy>
<dc:identifier type="dcterms:URI">https://www.tdx.cat/bitstream/10803/672192/1/MRR_PhD_THESIS.pdf</dc:identifier>
<uketdterms:checksum type="uketdterms:MD5">b17f8a007b83258c0d8ed84dcc314803</uketdterms:checksum>
<uketdterms:embargodate>cap</uketdterms:embargodate>
<dc:subject>Regulació genètica</dc:subject>
<dc:subject>Regulación genética</dc:subject>
<dc:subject>Genetic regulation</dc:subject>
<dc:subject>Cromatina</dc:subject>
<dc:subject>Chromatin</dc:subject>
<dc:subject>Genètica humana</dc:subject>
<dc:subject>Genética humana</dc:subject>
<dc:subject>Human genetics</dc:subject>
<dc:subject>Diabetis</dc:subject>
<dc:subject>Diabetes</dc:subject>
<dc:subject>Bioinformàtica</dc:subject>
<dc:subject>Bioinformática</dc:subject>
<dc:subject>Bioinformatics</dc:subject>
<dc:subject>Ciències Experimentals i Matemàtiques</dc:subject>
</uketd_dc:uketddc>
<?xml version="1.0" encoding="UTF-8" ?>
<metadata schemaLocation="http://www.lyncode.com/xoai http://www.lyncode.com/xsd/xoai.xsd">
<element name="dc">
<element name="contributor">
<element name="none">
<field name="value">Universitat de Barcelona. Facultat de Biologia</field>
</element>
<element name="author">
<element name="none">
<field name="value">Ramos Rodríguez, Mireia</field>
</element>
</element>
<element name="authoremail">
<element name="none">
<field name="value">mireiarr9@gmail.com</field>
</element>
</element>
<element name="authoremailshow">
<element name="none">
<field name="value">false</field>
</element>
</element>
<element name="director">
<element name="none">
<field name="value">Pasquali, Lorenzo</field>
</element>
</element>
<element name="tutor">
<element name="none">
<field name="value">Orozco López, Modesto</field>
</element>
</element>
</element>
<element name="date">
<element name="accessioned">
<element name="none">
<field name="value">2021-07-21T07:42:30Z</field>
</element>
</element>
<element name="available">
<element name="none">
<field name="value">2021-07-21T07:42:30Z</field>
</element>
</element>
<element name="issued">
<element name="none">
<field name="value">2020-11-06</field>
</element>
</element>
</element>
<element name="identifier">
<element name="uri">
<element name="none">
<field name="value">http://hdl.handle.net/10803/672192</field>
</element>
</element>
</element>
<element name="description">
<element name="none">
<field name="value">Programa de Doctorat en Biomedicina / Tesi realitzada a l'Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)</field>
</element>
<element name="abstract">
<element name="none">
<field name="value">Type 1 Diabetes (T1D) is a celltargeted autoimmune disease, leading to a reduction in pancreatic cell mass that renders patients insulindependent for life. In early stages of the disease, cells from the immune system infiltrate pancreatic islets in a process called insulitis. During this stage, a crosstalk is established between cells in the pancreatic islets and the infiltrating immune cells, mediated by the release of cytokines and chemokines. Studying the gene regulatory networks driving cell responses during insulitis, will allow us to pinpoint key gene pathways leading to cell lossoffunction and apoptosis, and also to understand the role cells have in their own demise. In the present thesis, we used two different cytokine cocktails, IFN and IFN + IL1, to model early and late insulitis, respectively. After exposing cells and pancreatic islets to such proinflammatory cytokines, we characterized the changes in their chromatin landscape, gene networks and protein profiles. Using both models, we observed dramatic chromatin remodeling in terms of accessibility and/or H3K27ac histone modification enrichment, coupled with upregulation of the nearby genes and increased abundance of the corresponding protein. Mining gene regulatory networks of cells exposed to IFN revealed two potential therapeutic interventions which were able to reduce interferon signature in cells: 1) Inhibition of bromodomain proteins, which resulted in a downregulation of IFNinduced HLAI and CXCL10 expression; 2) Baricitnib, a JAK1/2 inhibitor, which was able to reduce both IFNinduced HLAI and CXCL10 expression levels and cell apoptosis. In cells exposed to IFN + IL1, we were able to identify a subset of novel regulatory elements uncovered upon the exposure, which we named Induced Regulatory Elements (IREs). Such regions were enriched for T1Dassociated risk variants, suggesting that cells might carry a portion of T1D genetic risk. Interestingly, we identified two T1D lead variants overlapping IREs, in which the risk allele modulated the IRE enhancer activity, exposing a potential T1D mechanism acting through cells. To facilitate the access to these genomic data, together with other datasets relevant for the pancreatic islet community, we developed the Islet Regulome Browser (http://www.isletregulome.org/), a free web application that allows exploration and integration of pancreatic islet genomic data.</field>
</element>
</element>
</element>
<element name="format">
<element name="extent">
<element name="none">
<field name="value">221 p.</field>
</element>
</element>
<element name="mimetype">
<element name="none">
<field name="value">application/pdf</field>
</element>
</element>
</element>
<element name="language">
<element name="iso">
<element name="none">
<field name="value">eng</field>
</element>
</element>
</element>
<element name="publisher">
<element name="none">
<field name="value">Universitat de Barcelona</field>
</element>
</element>
<element name="rights">
<element name="license">
<element name="none">
<field name="value">L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by-nc/4.0/</field>
</element>
</element>
<element name="accessLevel">
<element name="none">
<field name="value">info:eu-repo/semantics/openAccess</field>
</element>
</element>
</element>
<element name="source">
<element name="none">
<field name="value">TDX (Tesis Doctorals en Xarxa)</field>
</element>
</element>
<element name="subject">
<element name="none">
<field name="value">Regulació genètica</field>
<field name="value">Regulación genética</field>
<field name="value">Genetic regulation</field>
<field name="value">Cromatina</field>
<field name="value">Chromatin</field>
<field name="value">Genètica humana</field>
<field name="value">Genética humana</field>
<field name="value">Human genetics</field>
<field name="value">Diabetis</field>
<field name="value">Diabetes</field>
<field name="value">Bioinformàtica</field>
<field name="value">Bioinformática</field>
<field name="value">Bioinformatics</field>
</element>
<element name="other">
<element name="none">
<field name="value">Ciències Experimentals i Matemàtiques</field>
</element>
</element>
<element name="udc">
<element name="none">
<field name="value">575</field>
<field name="value">61</field>
</element>
</element>
</element>
<element name="title">
<element name="none">
<field name="value">β-cells cis-regulatory networks and type 1 diabetes</field>
</element>
</element>
<element name="type">
<element name="none">
<field name="value">info:eu-repo/semantics/doctoralThesis</field>
<field name="value">info:eu-repo/semantics/publishedVersion</field>
</element>
</element>
<element name="embargo">
<element name="terms">
<element name="none">
<field name="value">cap</field>
</element>
</element>
</element>
</element>
<element name="bundles">
<element name="bundle">
<field name="name">ORIGINAL</field>
<element name="bitstreams">
<element name="bitstream">
<field name="name">MRR_PhD_THESIS.pdf</field>
<field name="originalName">MRR_PhD_THESIS.pdf</field>
<field name="format">application/pdf</field>
<field name="size">32775164</field>
<field name="url">https://www.tdx.cat/bitstream/10803/672192/1/MRR_PhD_THESIS.pdf</field>
<field name="checksum">b17f8a007b83258c0d8ed84dcc314803</field>
<field name="checksumAlgorithm">MD5</field>
<field name="sid">1</field>
<field name="drm">open access</field>
</element>
</element>
</element>
<element name="bundle">
<field name="name">CC-LICENSE</field>
<element name="bitstreams">
<element name="bitstream">
<field name="name">license_url</field>
<field name="originalName">license_url</field>
<field name="format">text/plain; charset=utf-8</field>
<field name="size">46</field>
<field name="url">https://www.tdx.cat/bitstream/10803/672192/2/license_url</field>
<field name="checksum">486e70aa6e7b0271de4953c01c4283fd</field>
<field name="checksumAlgorithm">MD5</field>
<field name="sid">2</field>
<field name="drm">open access</field>
</element>
<element name="bitstream">
<field name="name">license_text</field>
<field name="originalName">license_text</field>
<field name="format">text/html; charset=utf-8</field>
<field name="size">0</field>
<field name="url">https://www.tdx.cat/bitstream/10803/672192/3/license_text</field>
<field name="checksum">d41d8cd98f00b204e9800998ecf8427e</field>
<field name="checksumAlgorithm">MD5</field>
<field name="sid">3</field>
<field name="drm">open access</field>
</element>
<element name="bitstream">
<field name="name">license_rdf</field>
<field name="originalName">license_rdf</field>
<field name="format">application/rdf+xml; charset=utf-8</field>
<field name="size">0</field>
<field name="url">https://www.tdx.cat/bitstream/10803/672192/4/license_rdf</field>
<field name="checksum">d41d8cd98f00b204e9800998ecf8427e</field>
<field name="checksumAlgorithm">MD5</field>
<field name="sid">4</field>
<field name="drm">open access</field>
</element>
</element>
</element>
<element name="bundle">
<field name="name">MEDIA_DOCUMENT</field>
<element name="bitstreams">
<element name="bitstream">
<field name="name">MRR_PhD_THESIS.pdf.xml</field>
<field name="originalName">MRR_PhD_THESIS.pdf.xml</field>
<field name="description">Document Consulta</field>
<field name="format">text/xml</field>
<field name="size">105</field>
<field name="url">https://www.tdx.cat/bitstream/10803/672192/5/MRR_PhD_THESIS.pdf.xml</field>
<field name="checksum">f14b4095fcca81ed82693b2ac527c118</field>
<field name="checksumAlgorithm">MD5</field>
<field name="sid">5</field>
<field name="drm">open access</field>
</element>
</element>
</element>
</element>
<element name="others">
<field name="handle">10803/672192</field>
<field name="identifier">oai:www.tdx.cat:10803/672192</field>
<field name="lastModifyDate">2021-07-21 10:12:59.924</field>
<field name="drm">open access</field>
</element>
<element name="repository">
<field name="name">TDX (Tesis Doctorals en Xarxa)</field>
<field name="mail">pir@csuc.cat</field>
</element>
</metadata>